(1)
Clarification to Provide Further Understanding of the Conduct and Design of TROPIC: A Phase 3 Trial of Cabazitaxel versus Mitoxantrone in Patients With Metastatic Castration-Resistant Prostate Cancer. Arch Ital Urol Androl 2016, 88 (1), 72-73. https://doi.org/10.4081/aiua.2016.1.72.